Regencell Bioscience Holdings Limited

NasdaqCM:RGC Stock Report

Market Cap: US$12.8b

Regencell Bioscience Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RGC?
Owner TypeNumber of SharesOwnership Percentage
Institutions943,8180.191%
General Public54,463,41011%
Individual Insiders439,081,68088.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 88.99% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
88.6%
Yat-Gai Au
437,896,116US$11.3b0%no data
0.12%
Hoor Han Lo
604,050US$15.6m0%no data
0.12%
Yat-Pui Au
581,514US$15.0m0%no data
0.084%
Geode Capital Management, LLC
415,569US$10.7m0.6%no data
0.059%
FMR LLC
292,092US$7.5m0.2%no data
0.0064%
Marex Group plc
31,600US$815.2k0%0.01%
0.0064%
GSA Capital Partners LLP
31,569US$813.9k0%0.05%
0.006%
Vident Asset Management
29,588US$762.9k-1.16%no data
0.0054%
Squarepoint OPS LLC
26,613US$686.4k2.31%no data
0.0048%
UBS Asset Management AG
23,885US$616.2k31.2%no data
0.0041%
Morgan Stanley
20,078US$518.0k-6.28%no data
0.0035%
Bank of America Corporation
17,172US$442.7k59,100%no data
0.0024%
State Street Global Advisors, Inc.
11,851US$306.2k204%no data
0.002%
Legal & General Investment Management Limited
9,903US$255.2k0%no data
0.0017%
LPL Financial LLC
8,596US$222.0k0%no data
0.0017%
Amundi Asset Management SAS
8,595US$222.0k0%no data
0.00099%
BlackRock, Inc.
4,918US$126.3k1.09%no data
0.00045%
Desjardins Global Asset Management Inc.
2,231US$57.4k0%no data
0.0003%
Mackenzie Financial Corporation
1,508US$38.3k7.1%no data
0.0003%
Goldman Sachs Asset Management, L.P.
1,460US$38.3k0%no data
0.00025%
BNY Asset Management
1,249US$31.9k-3.1%no data
0.00022%
GF Fund Management Co., Ltd.
1,064US$28.1k0%no data
0.00019%
EverSource Wealth Advisors, LLC
918US$24.2k66.9%no data
0.00017%
JPMorgan Chase & Co.
845US$21.7k0%no data
0.00015%
Russell Investment Management, LLC
760US$19.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/24 13:15
End of Day Share Price 2026/05/22 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Regencell Bioscience Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.